The use of breast ultrasound for prediction of pathologic complete response in different subtypes of early breast cancer within the WSG-ADAPT subtrials
We assessed the value of breast ultrasound (US) performed at week 3 and 6 and at the end (EOT) of neoadjuvant therapy (NAT) for prediction of pathologic complete response (pCR, ypT0/is ypN0) in patients with HR+/HER2+, HR-/HER2-or HR-/HER2+ early breast cancer enrolled in the WSG-ADAPT subtrials.
Autor*in: |
Graeser, Monika [verfasserIn] |
---|
Format: |
E-Artikel |
---|---|
Sprache: |
Englisch |
Erschienen: |
2021 |
---|
Schlagwörter: |
---|
Umfang: |
9 |
---|
Übergeordnetes Werk: |
Enthalten in: The clinical outcomes of endovenous microwave and laser ablation for varicose veins: A prospective study - Yang, Lin ELSEVIER, 2020, Amsterdam [u.a.] |
---|---|
Übergeordnetes Werk: |
volume:59 ; year:2021 ; pages:58-66 ; extent:9 |
Links: |
---|
DOI / URN: |
10.1016/j.breast.2021.06.001 |
---|
Katalog-ID: |
ELV055235212 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | ELV055235212 | ||
003 | DE-627 | ||
005 | 20230624220604.0 | ||
007 | cr uuu---uuuuu | ||
008 | 220105s2021 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.breast.2021.06.001 |2 doi | |
028 | 5 | 2 | |a /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001827.pica |
035 | |a (DE-627)ELV055235212 | ||
035 | |a (ELSEVIER)S0960-9776(21)00388-X | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
082 | 0 | 4 | |a 610 |q VZ |
084 | |a 44.65 |2 bkl | ||
100 | 1 | |a Graeser, Monika |e verfasserin |4 aut | |
245 | 1 | 4 | |a The use of breast ultrasound for prediction of pathologic complete response in different subtypes of early breast cancer within the WSG-ADAPT subtrials |
264 | 1 | |c 2021 | |
300 | |a 9 | ||
336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
337 | |a nicht spezifiziert |b z |2 rdamedia | ||
338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
520 | |a We assessed the value of breast ultrasound (US) performed at week 3 and 6 and at the end (EOT) of neoadjuvant therapy (NAT) for prediction of pathologic complete response (pCR, ypT0/is ypN0) in patients with HR+/HER2+, HR-/HER2-or HR-/HER2+ early breast cancer enrolled in the WSG-ADAPT subtrials. | ||
650 | 7 | |a Neoadjuvant therapy |2 Elsevier | |
650 | 7 | |a Ultrasonography |2 Elsevier | |
650 | 7 | |a Pathologic complete response |2 Elsevier | |
650 | 7 | |a Breast neoplasm |2 Elsevier | |
700 | 1 | |a Harbeck, Nadia |4 oth | |
700 | 1 | |a Gluz, Oleg |4 oth | |
700 | 1 | |a Würstlein, Rachel |4 oth | |
700 | 1 | |a zu Eulenburg, Christine |4 oth | |
700 | 1 | |a Schumacher, Claudia |4 oth | |
700 | 1 | |a Grischke, Eva-Maria |4 oth | |
700 | 1 | |a Forstbauer, Helmut |4 oth | |
700 | 1 | |a Dimpfl, Moritz |4 oth | |
700 | 1 | |a Braun, Michael |4 oth | |
700 | 1 | |a Christgen, Matthias |4 oth | |
700 | 1 | |a Kreipe, Hans Heinrich |4 oth | |
700 | 1 | |a Potenberg, Jochem |4 oth | |
700 | 1 | |a von Schumann, Raquel |4 oth | |
700 | 1 | |a Aktas, Bahriye |4 oth | |
700 | 1 | |a Kolberg-Liedtke, Cornelia |4 oth | |
700 | 1 | |a Kümmel, Sherko |4 oth | |
700 | 1 | |a Nitz, Ulrike |4 oth | |
773 | 0 | 8 | |i Enthalten in |n Elsevier |a Yang, Lin ELSEVIER |t The clinical outcomes of endovenous microwave and laser ablation for varicose veins: A prospective study |d 2020 |g Amsterdam [u.a.] |w (DE-627)ELV004843835 |
773 | 1 | 8 | |g volume:59 |g year:2021 |g pages:58-66 |g extent:9 |
856 | 4 | 0 | |u https://doi.org/10.1016/j.breast.2021.06.001 |3 Volltext |
912 | |a GBV_USEFLAG_U | ||
912 | |a GBV_ELV | ||
912 | |a SYSFLAG_U | ||
912 | |a SSG-OLC-PHA | ||
936 | b | k | |a 44.65 |j Chirurgie |q VZ |
951 | |a AR | ||
952 | |d 59 |j 2021 |h 58-66 |g 9 |
author_variant |
m g mg |
---|---|
matchkey_str |
graesermonikaharbecknadiagluzolegwrstlei:2021----:huefratlrsudopeitooptooicmltrsosidfeetutpsfalbes |
hierarchy_sort_str |
2021 |
bklnumber |
44.65 |
publishDate |
2021 |
allfields |
10.1016/j.breast.2021.06.001 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001827.pica (DE-627)ELV055235212 (ELSEVIER)S0960-9776(21)00388-X DE-627 ger DE-627 rakwb eng 610 VZ 44.65 bkl Graeser, Monika verfasserin aut The use of breast ultrasound for prediction of pathologic complete response in different subtypes of early breast cancer within the WSG-ADAPT subtrials 2021 9 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier We assessed the value of breast ultrasound (US) performed at week 3 and 6 and at the end (EOT) of neoadjuvant therapy (NAT) for prediction of pathologic complete response (pCR, ypT0/is ypN0) in patients with HR+/HER2+, HR-/HER2-or HR-/HER2+ early breast cancer enrolled in the WSG-ADAPT subtrials. Neoadjuvant therapy Elsevier Ultrasonography Elsevier Pathologic complete response Elsevier Breast neoplasm Elsevier Harbeck, Nadia oth Gluz, Oleg oth Würstlein, Rachel oth zu Eulenburg, Christine oth Schumacher, Claudia oth Grischke, Eva-Maria oth Forstbauer, Helmut oth Dimpfl, Moritz oth Braun, Michael oth Christgen, Matthias oth Kreipe, Hans Heinrich oth Potenberg, Jochem oth von Schumann, Raquel oth Aktas, Bahriye oth Kolberg-Liedtke, Cornelia oth Kümmel, Sherko oth Nitz, Ulrike oth Enthalten in Elsevier Yang, Lin ELSEVIER The clinical outcomes of endovenous microwave and laser ablation for varicose veins: A prospective study 2020 Amsterdam [u.a.] (DE-627)ELV004843835 volume:59 year:2021 pages:58-66 extent:9 https://doi.org/10.1016/j.breast.2021.06.001 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.65 Chirurgie VZ AR 59 2021 58-66 9 |
spelling |
10.1016/j.breast.2021.06.001 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001827.pica (DE-627)ELV055235212 (ELSEVIER)S0960-9776(21)00388-X DE-627 ger DE-627 rakwb eng 610 VZ 44.65 bkl Graeser, Monika verfasserin aut The use of breast ultrasound for prediction of pathologic complete response in different subtypes of early breast cancer within the WSG-ADAPT subtrials 2021 9 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier We assessed the value of breast ultrasound (US) performed at week 3 and 6 and at the end (EOT) of neoadjuvant therapy (NAT) for prediction of pathologic complete response (pCR, ypT0/is ypN0) in patients with HR+/HER2+, HR-/HER2-or HR-/HER2+ early breast cancer enrolled in the WSG-ADAPT subtrials. Neoadjuvant therapy Elsevier Ultrasonography Elsevier Pathologic complete response Elsevier Breast neoplasm Elsevier Harbeck, Nadia oth Gluz, Oleg oth Würstlein, Rachel oth zu Eulenburg, Christine oth Schumacher, Claudia oth Grischke, Eva-Maria oth Forstbauer, Helmut oth Dimpfl, Moritz oth Braun, Michael oth Christgen, Matthias oth Kreipe, Hans Heinrich oth Potenberg, Jochem oth von Schumann, Raquel oth Aktas, Bahriye oth Kolberg-Liedtke, Cornelia oth Kümmel, Sherko oth Nitz, Ulrike oth Enthalten in Elsevier Yang, Lin ELSEVIER The clinical outcomes of endovenous microwave and laser ablation for varicose veins: A prospective study 2020 Amsterdam [u.a.] (DE-627)ELV004843835 volume:59 year:2021 pages:58-66 extent:9 https://doi.org/10.1016/j.breast.2021.06.001 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.65 Chirurgie VZ AR 59 2021 58-66 9 |
allfields_unstemmed |
10.1016/j.breast.2021.06.001 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001827.pica (DE-627)ELV055235212 (ELSEVIER)S0960-9776(21)00388-X DE-627 ger DE-627 rakwb eng 610 VZ 44.65 bkl Graeser, Monika verfasserin aut The use of breast ultrasound for prediction of pathologic complete response in different subtypes of early breast cancer within the WSG-ADAPT subtrials 2021 9 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier We assessed the value of breast ultrasound (US) performed at week 3 and 6 and at the end (EOT) of neoadjuvant therapy (NAT) for prediction of pathologic complete response (pCR, ypT0/is ypN0) in patients with HR+/HER2+, HR-/HER2-or HR-/HER2+ early breast cancer enrolled in the WSG-ADAPT subtrials. Neoadjuvant therapy Elsevier Ultrasonography Elsevier Pathologic complete response Elsevier Breast neoplasm Elsevier Harbeck, Nadia oth Gluz, Oleg oth Würstlein, Rachel oth zu Eulenburg, Christine oth Schumacher, Claudia oth Grischke, Eva-Maria oth Forstbauer, Helmut oth Dimpfl, Moritz oth Braun, Michael oth Christgen, Matthias oth Kreipe, Hans Heinrich oth Potenberg, Jochem oth von Schumann, Raquel oth Aktas, Bahriye oth Kolberg-Liedtke, Cornelia oth Kümmel, Sherko oth Nitz, Ulrike oth Enthalten in Elsevier Yang, Lin ELSEVIER The clinical outcomes of endovenous microwave and laser ablation for varicose veins: A prospective study 2020 Amsterdam [u.a.] (DE-627)ELV004843835 volume:59 year:2021 pages:58-66 extent:9 https://doi.org/10.1016/j.breast.2021.06.001 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.65 Chirurgie VZ AR 59 2021 58-66 9 |
allfieldsGer |
10.1016/j.breast.2021.06.001 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001827.pica (DE-627)ELV055235212 (ELSEVIER)S0960-9776(21)00388-X DE-627 ger DE-627 rakwb eng 610 VZ 44.65 bkl Graeser, Monika verfasserin aut The use of breast ultrasound for prediction of pathologic complete response in different subtypes of early breast cancer within the WSG-ADAPT subtrials 2021 9 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier We assessed the value of breast ultrasound (US) performed at week 3 and 6 and at the end (EOT) of neoadjuvant therapy (NAT) for prediction of pathologic complete response (pCR, ypT0/is ypN0) in patients with HR+/HER2+, HR-/HER2-or HR-/HER2+ early breast cancer enrolled in the WSG-ADAPT subtrials. Neoadjuvant therapy Elsevier Ultrasonography Elsevier Pathologic complete response Elsevier Breast neoplasm Elsevier Harbeck, Nadia oth Gluz, Oleg oth Würstlein, Rachel oth zu Eulenburg, Christine oth Schumacher, Claudia oth Grischke, Eva-Maria oth Forstbauer, Helmut oth Dimpfl, Moritz oth Braun, Michael oth Christgen, Matthias oth Kreipe, Hans Heinrich oth Potenberg, Jochem oth von Schumann, Raquel oth Aktas, Bahriye oth Kolberg-Liedtke, Cornelia oth Kümmel, Sherko oth Nitz, Ulrike oth Enthalten in Elsevier Yang, Lin ELSEVIER The clinical outcomes of endovenous microwave and laser ablation for varicose veins: A prospective study 2020 Amsterdam [u.a.] (DE-627)ELV004843835 volume:59 year:2021 pages:58-66 extent:9 https://doi.org/10.1016/j.breast.2021.06.001 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.65 Chirurgie VZ AR 59 2021 58-66 9 |
allfieldsSound |
10.1016/j.breast.2021.06.001 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001827.pica (DE-627)ELV055235212 (ELSEVIER)S0960-9776(21)00388-X DE-627 ger DE-627 rakwb eng 610 VZ 44.65 bkl Graeser, Monika verfasserin aut The use of breast ultrasound for prediction of pathologic complete response in different subtypes of early breast cancer within the WSG-ADAPT subtrials 2021 9 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier We assessed the value of breast ultrasound (US) performed at week 3 and 6 and at the end (EOT) of neoadjuvant therapy (NAT) for prediction of pathologic complete response (pCR, ypT0/is ypN0) in patients with HR+/HER2+, HR-/HER2-or HR-/HER2+ early breast cancer enrolled in the WSG-ADAPT subtrials. Neoadjuvant therapy Elsevier Ultrasonography Elsevier Pathologic complete response Elsevier Breast neoplasm Elsevier Harbeck, Nadia oth Gluz, Oleg oth Würstlein, Rachel oth zu Eulenburg, Christine oth Schumacher, Claudia oth Grischke, Eva-Maria oth Forstbauer, Helmut oth Dimpfl, Moritz oth Braun, Michael oth Christgen, Matthias oth Kreipe, Hans Heinrich oth Potenberg, Jochem oth von Schumann, Raquel oth Aktas, Bahriye oth Kolberg-Liedtke, Cornelia oth Kümmel, Sherko oth Nitz, Ulrike oth Enthalten in Elsevier Yang, Lin ELSEVIER The clinical outcomes of endovenous microwave and laser ablation for varicose veins: A prospective study 2020 Amsterdam [u.a.] (DE-627)ELV004843835 volume:59 year:2021 pages:58-66 extent:9 https://doi.org/10.1016/j.breast.2021.06.001 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.65 Chirurgie VZ AR 59 2021 58-66 9 |
language |
English |
source |
Enthalten in The clinical outcomes of endovenous microwave and laser ablation for varicose veins: A prospective study Amsterdam [u.a.] volume:59 year:2021 pages:58-66 extent:9 |
sourceStr |
Enthalten in The clinical outcomes of endovenous microwave and laser ablation for varicose veins: A prospective study Amsterdam [u.a.] volume:59 year:2021 pages:58-66 extent:9 |
format_phy_str_mv |
Article |
bklname |
Chirurgie |
institution |
findex.gbv.de |
topic_facet |
Neoadjuvant therapy Ultrasonography Pathologic complete response Breast neoplasm |
dewey-raw |
610 |
isfreeaccess_bool |
false |
container_title |
The clinical outcomes of endovenous microwave and laser ablation for varicose veins: A prospective study |
authorswithroles_txt_mv |
Graeser, Monika @@aut@@ Harbeck, Nadia @@oth@@ Gluz, Oleg @@oth@@ Würstlein, Rachel @@oth@@ zu Eulenburg, Christine @@oth@@ Schumacher, Claudia @@oth@@ Grischke, Eva-Maria @@oth@@ Forstbauer, Helmut @@oth@@ Dimpfl, Moritz @@oth@@ Braun, Michael @@oth@@ Christgen, Matthias @@oth@@ Kreipe, Hans Heinrich @@oth@@ Potenberg, Jochem @@oth@@ von Schumann, Raquel @@oth@@ Aktas, Bahriye @@oth@@ Kolberg-Liedtke, Cornelia @@oth@@ Kümmel, Sherko @@oth@@ Nitz, Ulrike @@oth@@ |
publishDateDaySort_date |
2021-01-01T00:00:00Z |
hierarchy_top_id |
ELV004843835 |
dewey-sort |
3610 |
id |
ELV055235212 |
language_de |
englisch |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV055235212</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230624220604.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">220105s2021 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.breast.2021.06.001</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">/cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001827.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV055235212</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0960-9776(21)00388-X</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.65</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Graeser, Monika</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="4"><subfield code="a">The use of breast ultrasound for prediction of pathologic complete response in different subtypes of early breast cancer within the WSG-ADAPT subtrials</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2021</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">9</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">We assessed the value of breast ultrasound (US) performed at week 3 and 6 and at the end (EOT) of neoadjuvant therapy (NAT) for prediction of pathologic complete response (pCR, ypT0/is ypN0) in patients with HR+/HER2+, HR-/HER2-or HR-/HER2+ early breast cancer enrolled in the WSG-ADAPT subtrials.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Neoadjuvant therapy</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Ultrasonography</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Pathologic complete response</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Breast neoplasm</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Harbeck, Nadia</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Gluz, Oleg</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Würstlein, Rachel</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">zu Eulenburg, Christine</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Schumacher, Claudia</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Grischke, Eva-Maria</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Forstbauer, Helmut</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Dimpfl, Moritz</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Braun, Michael</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Christgen, Matthias</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kreipe, Hans Heinrich</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Potenberg, Jochem</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">von Schumann, Raquel</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Aktas, Bahriye</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kolberg-Liedtke, Cornelia</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kümmel, Sherko</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Nitz, Ulrike</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier</subfield><subfield code="a">Yang, Lin ELSEVIER</subfield><subfield code="t">The clinical outcomes of endovenous microwave and laser ablation for varicose veins: A prospective study</subfield><subfield code="d">2020</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV004843835</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:59</subfield><subfield code="g">year:2021</subfield><subfield code="g">pages:58-66</subfield><subfield code="g">extent:9</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.breast.2021.06.001</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.65</subfield><subfield code="j">Chirurgie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">59</subfield><subfield code="j">2021</subfield><subfield code="h">58-66</subfield><subfield code="g">9</subfield></datafield></record></collection>
|
author |
Graeser, Monika |
spellingShingle |
Graeser, Monika ddc 610 bkl 44.65 Elsevier Neoadjuvant therapy Elsevier Ultrasonography Elsevier Pathologic complete response Elsevier Breast neoplasm The use of breast ultrasound for prediction of pathologic complete response in different subtypes of early breast cancer within the WSG-ADAPT subtrials |
authorStr |
Graeser, Monika |
ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV004843835 |
format |
electronic Article |
dewey-ones |
610 - Medicine & health |
delete_txt_mv |
keep |
author_role |
aut |
collection |
elsevier |
remote_str |
true |
illustrated |
Not Illustrated |
topic_title |
610 VZ 44.65 bkl The use of breast ultrasound for prediction of pathologic complete response in different subtypes of early breast cancer within the WSG-ADAPT subtrials Neoadjuvant therapy Elsevier Ultrasonography Elsevier Pathologic complete response Elsevier Breast neoplasm Elsevier |
topic |
ddc 610 bkl 44.65 Elsevier Neoadjuvant therapy Elsevier Ultrasonography Elsevier Pathologic complete response Elsevier Breast neoplasm |
topic_unstemmed |
ddc 610 bkl 44.65 Elsevier Neoadjuvant therapy Elsevier Ultrasonography Elsevier Pathologic complete response Elsevier Breast neoplasm |
topic_browse |
ddc 610 bkl 44.65 Elsevier Neoadjuvant therapy Elsevier Ultrasonography Elsevier Pathologic complete response Elsevier Breast neoplasm |
format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
format_main_str_mv |
Text Zeitschrift/Artikel |
carriertype_str_mv |
zu |
author2_variant |
n h nh o g og r w rw e c z ec ecz c s cs e m g emg h f hf m d md m b mb m c mc h h k hh hhk j p jp s r v sr srv b a ba c k l ckl s k sk u n un |
hierarchy_parent_title |
The clinical outcomes of endovenous microwave and laser ablation for varicose veins: A prospective study |
hierarchy_parent_id |
ELV004843835 |
dewey-tens |
610 - Medicine & health |
hierarchy_top_title |
The clinical outcomes of endovenous microwave and laser ablation for varicose veins: A prospective study |
isfreeaccess_txt |
false |
familylinks_str_mv |
(DE-627)ELV004843835 |
title |
The use of breast ultrasound for prediction of pathologic complete response in different subtypes of early breast cancer within the WSG-ADAPT subtrials |
ctrlnum |
(DE-627)ELV055235212 (ELSEVIER)S0960-9776(21)00388-X |
title_full |
The use of breast ultrasound for prediction of pathologic complete response in different subtypes of early breast cancer within the WSG-ADAPT subtrials |
author_sort |
Graeser, Monika |
journal |
The clinical outcomes of endovenous microwave and laser ablation for varicose veins: A prospective study |
journalStr |
The clinical outcomes of endovenous microwave and laser ablation for varicose veins: A prospective study |
lang_code |
eng |
isOA_bool |
false |
dewey-hundreds |
600 - Technology |
recordtype |
marc |
publishDateSort |
2021 |
contenttype_str_mv |
zzz |
container_start_page |
58 |
author_browse |
Graeser, Monika |
container_volume |
59 |
physical |
9 |
class |
610 VZ 44.65 bkl |
format_se |
Elektronische Aufsätze |
author-letter |
Graeser, Monika |
doi_str_mv |
10.1016/j.breast.2021.06.001 |
dewey-full |
610 |
title_sort |
use of breast ultrasound for prediction of pathologic complete response in different subtypes of early breast cancer within the wsg-adapt subtrials |
title_auth |
The use of breast ultrasound for prediction of pathologic complete response in different subtypes of early breast cancer within the WSG-ADAPT subtrials |
abstract |
We assessed the value of breast ultrasound (US) performed at week 3 and 6 and at the end (EOT) of neoadjuvant therapy (NAT) for prediction of pathologic complete response (pCR, ypT0/is ypN0) in patients with HR+/HER2+, HR-/HER2-or HR-/HER2+ early breast cancer enrolled in the WSG-ADAPT subtrials. |
abstractGer |
We assessed the value of breast ultrasound (US) performed at week 3 and 6 and at the end (EOT) of neoadjuvant therapy (NAT) for prediction of pathologic complete response (pCR, ypT0/is ypN0) in patients with HR+/HER2+, HR-/HER2-or HR-/HER2+ early breast cancer enrolled in the WSG-ADAPT subtrials. |
abstract_unstemmed |
We assessed the value of breast ultrasound (US) performed at week 3 and 6 and at the end (EOT) of neoadjuvant therapy (NAT) for prediction of pathologic complete response (pCR, ypT0/is ypN0) in patients with HR+/HER2+, HR-/HER2-or HR-/HER2+ early breast cancer enrolled in the WSG-ADAPT subtrials. |
collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA |
title_short |
The use of breast ultrasound for prediction of pathologic complete response in different subtypes of early breast cancer within the WSG-ADAPT subtrials |
url |
https://doi.org/10.1016/j.breast.2021.06.001 |
remote_bool |
true |
author2 |
Harbeck, Nadia Gluz, Oleg Würstlein, Rachel zu Eulenburg, Christine Schumacher, Claudia Grischke, Eva-Maria Forstbauer, Helmut Dimpfl, Moritz Braun, Michael Christgen, Matthias Kreipe, Hans Heinrich Potenberg, Jochem von Schumann, Raquel Aktas, Bahriye Kolberg-Liedtke, Cornelia Kümmel, Sherko Nitz, Ulrike |
author2Str |
Harbeck, Nadia Gluz, Oleg Würstlein, Rachel zu Eulenburg, Christine Schumacher, Claudia Grischke, Eva-Maria Forstbauer, Helmut Dimpfl, Moritz Braun, Michael Christgen, Matthias Kreipe, Hans Heinrich Potenberg, Jochem von Schumann, Raquel Aktas, Bahriye Kolberg-Liedtke, Cornelia Kümmel, Sherko Nitz, Ulrike |
ppnlink |
ELV004843835 |
mediatype_str_mv |
z |
isOA_txt |
false |
hochschulschrift_bool |
false |
author2_role |
oth oth oth oth oth oth oth oth oth oth oth oth oth oth oth oth oth |
doi_str |
10.1016/j.breast.2021.06.001 |
up_date |
2024-07-06T16:59:51.941Z |
_version_ |
1803849765427871744 |
fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV055235212</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230624220604.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">220105s2021 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.breast.2021.06.001</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">/cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001827.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV055235212</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0960-9776(21)00388-X</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.65</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Graeser, Monika</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="4"><subfield code="a">The use of breast ultrasound for prediction of pathologic complete response in different subtypes of early breast cancer within the WSG-ADAPT subtrials</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2021</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">9</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">We assessed the value of breast ultrasound (US) performed at week 3 and 6 and at the end (EOT) of neoadjuvant therapy (NAT) for prediction of pathologic complete response (pCR, ypT0/is ypN0) in patients with HR+/HER2+, HR-/HER2-or HR-/HER2+ early breast cancer enrolled in the WSG-ADAPT subtrials.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Neoadjuvant therapy</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Ultrasonography</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Pathologic complete response</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Breast neoplasm</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Harbeck, Nadia</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Gluz, Oleg</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Würstlein, Rachel</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">zu Eulenburg, Christine</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Schumacher, Claudia</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Grischke, Eva-Maria</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Forstbauer, Helmut</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Dimpfl, Moritz</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Braun, Michael</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Christgen, Matthias</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kreipe, Hans Heinrich</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Potenberg, Jochem</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">von Schumann, Raquel</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Aktas, Bahriye</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kolberg-Liedtke, Cornelia</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kümmel, Sherko</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Nitz, Ulrike</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier</subfield><subfield code="a">Yang, Lin ELSEVIER</subfield><subfield code="t">The clinical outcomes of endovenous microwave and laser ablation for varicose veins: A prospective study</subfield><subfield code="d">2020</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV004843835</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:59</subfield><subfield code="g">year:2021</subfield><subfield code="g">pages:58-66</subfield><subfield code="g">extent:9</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.breast.2021.06.001</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.65</subfield><subfield code="j">Chirurgie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">59</subfield><subfield code="j">2021</subfield><subfield code="h">58-66</subfield><subfield code="g">9</subfield></datafield></record></collection>
|
score |
7.4004087 |